Connectome-based models can predict early symptom improvement in major depressive disorder

Yumeng Ju,Corey Horien,Wentao Chen,Weilong Guo,Xiaowen Lu,Jinrong Sun,Qiangli Dong,Bangshan Liu,Jin Liu,Danfeng Yan,Mi Wang,Liang Zhang,Hua Guo,Futao Zhao,Yan Zhang,Xilin Shen,R Todd Constable,Lingjiang Li,R. Todd Constable
DOI: https://doi.org/10.1016/j.jad.2020.04.028
IF: 6.533
2020-08-01
Journal of Affective Disorders
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Major depressive disorder (MDD) is a debilitating mental illness with more than 50% of patients not achieving an adequate response using first-line treatments. Reliable models that predict antidepressant treatment outcome are needed to guide clinical decision making. We aimed to build predictive models of treatment improvement for MDD patients using machine learning approaches based on fMRI resting-state functional connectivity patterns.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Resting-state fMRI data were acquired from 192 untreated MDD patients at recruitment, and their severity of depression was assessed by Hamilton Rating Scale for Depression (HAMD) at baseline. Patients were given medication after the initial MR scan and their symptoms were monitored through HAMD for a period of six months. Connectome-based predictive modeling (CPM) algorithms were implemented to predict the improvement in HAMD score at one month from resting-state connectivity at baseline. Additionally, by selectively combining the features from all leave-one-out iterations in the model building stage, we created a consensus model that could be generalized to predict improvement in HAMD score in samples of non-overlapping subjects at different time points.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Using baseline functional connectivity, CPM successfully predicted symptom improvement of depression at one month. In addition, a consensus 'MDD improvement model' could predict symptom improvement for novel individuals at the two-week, one-month, two-month and three-month time points after antidepressant treatment.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Individual pre-treatment functional brain networks contain meaningful information that can be gleaned to build predictors of treatment outcome. The identified MDD improvement networks could be an appropriate biomarker for predicting individual therapeutic response of antidepressant treatment. Replication and validation using other large datasets will be a key next step before these models can be used in clinical practice.</p>
psychiatry,clinical neurology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to predict early symptom improvement in patients with Major Depressive Disorder (MDD) using connectomics - based models. Specifically, the researchers hope to predict whether these patients will have significant improvement in depressive symptoms after one month of antidepressant treatment by analyzing the whole - brain functional connectivity patterns of patients before treatment. This study aims to identify neuroimaging biomarkers that can predict antidepressant treatment response, thereby providing more accurate prognostic assessment tools for clinical practice. The research background mentions that approximately 50% of MDD patients do not respond well to first - line antidepressant treatment, and antidepressant drugs usually take several weeks to take effect, and there are also large differences in patients' responses to drugs. Therefore, it is of great clinical significance to identify prognostic indicators that can predict the efficacy of antidepressants before the start of treatment. However, although some studies have explored possible predictors of MDD treatment outcomes through individual neuroimaging features, establishing truly treatment - response - related neuroimaging biomarkers still faces challenges, and a great deal of work is still required to translate research findings into clinical applications. To fill this gap, this study adopted a data - driven machine - learning technique - Connectome - based Predictive Modeling (CPM) - to predict symptom improvement in MDD patients based on whole - brain functional connectivity. The main objectives of the study include: 1) To examine whether baseline functional connectivity patterns can predict individual symptom improvement during antidepressant treatment after one month; 2) To construct a consensus model for predicting symptom improvement after one month and identify the functional connectivity patterns in the model; 3) To test whether the model for predicting symptom improvement within one month can predict treatment response at other time points; 4) To examine the stability of the identified network after six months of treatment.